What's in Rosenberg European Academy of Ayurveda's pipeline?

Rosenberg European Academy of Ayurveda has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Rosenberg European Academy of Ayurveda's portfolio?

Top competitors by shared drug class: Universität Duisburg-Essen, Weleda AG.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/rosenberg-european-academy-of-ayurveda.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Rosenberg European Academy of Ayurveda — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Rosenberg European Academy of Ayurveda pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Phyllanthus niruri	Phyllanthus niruri	marketed	Herbal/botanical preparation		Hepatology; Urology

Therapeutic area mix

Hepatology; Urology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Universität Duisburg-Essen · 1 shared drug class
Weleda AG · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Rosenberg European Academy of Ayurveda:

Cite this brief

Drug Landscape (2026). Rosenberg European Academy of Ayurveda — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/rosenberg-european-academy-of-ayurveda. Accessed 2026-05-18.